Annual Current Liabilities
$51.27 M
-$16.93 M-24.83%
31 December 2023
Summary:
Nektar Therapeutics annual total current liabilities is currently $51.27 million, with the most recent change of -$16.93 million (-24.83%) on 31 December 2023. During the last 3 years, it has fallen by -$64.51 million (-55.72%). NKTR annual current liabilities is now -85.51% below its all-time high of $353.89 million, reached on 31 December 2019.NKTR Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$67.58 M
+$10.26 M+17.89%
30 September 2024
Summary:
Nektar Therapeutics quarterly total current liabilities is currently $67.58 million, with the most recent change of +$10.26 million (+17.89%) on 30 September 2024. Over the past year, it has increased by +$15.47 million (+29.69%). NKTR quarterly current liabilities is now -82.10% below its all-time high of $377.47 million, reached on 31 March 2020.NKTR Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.8% | +29.7% |
| 3 y3 years | -55.7% | -51.7% |
| 5 y5 years | -37.5% | -46.1% |
NKTR Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -55.7% | at low | -51.7% | +33.3% |
| 5 y | 5 years | -85.5% | at low | -82.1% | +33.3% |
| alltime | all time | -85.5% | +3562.1% | -82.1% | +4727.4% |
Nektar Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $67.58 M(+17.9%) |
| June 2024 | - | $57.33 M(+9.4%) |
| Mar 2024 | - | $52.41 M(+2.2%) |
| Dec 2023 | $51.27 M(-24.8%) | $51.27 M(-1.6%) |
| Sept 2023 | - | $52.11 M(+2.8%) |
| June 2023 | - | $50.69 M(-15.3%) |
| Mar 2023 | - | $59.88 M(-12.2%) |
| Dec 2022 | $68.20 M(-19.9%) | $68.20 M(-18.8%) |
| Sept 2022 | - | $83.99 M(-20.0%) |
| June 2022 | - | $104.98 M(-0.3%) |
| Mar 2022 | - | $105.28 M(+23.6%) |
| Dec 2021 | $85.20 M(-26.4%) | $85.20 M(-39.1%) |
| Sept 2021 | - | $139.97 M(+6.8%) |
| June 2021 | - | $131.02 M(+6.0%) |
| Mar 2021 | - | $123.63 M(+6.8%) |
| Dec 2020 | $115.78 M(-67.3%) | $115.78 M(-8.5%) |
| Sept 2020 | - | $126.50 M(+2.1%) |
| June 2020 | - | $123.96 M(-67.2%) |
| Mar 2020 | - | $377.47 M(+6.7%) |
| Dec 2019 | $353.89 M(+331.6%) | $353.89 M(+182.3%) |
| Sept 2019 | - | $125.35 M(+10.6%) |
| June 2019 | - | $113.37 M(+13.7%) |
| Mar 2019 | - | $99.72 M(+21.6%) |
| Dec 2018 | $82.00 M(+46.0%) | $82.00 M(-24.1%) |
| Sept 2018 | - | $108.08 M(+11.5%) |
| June 2018 | - | $96.90 M(+20.1%) |
| Mar 2018 | - | $80.70 M(+43.7%) |
| Dec 2017 | $56.16 M(-22.2%) | $56.16 M(-39.3%) |
| Sept 2017 | - | $92.54 M(+27.4%) |
| June 2017 | - | $72.61 M(-7.5%) |
| Mar 2017 | - | $78.52 M(+8.7%) |
| Dec 2016 | $72.22 M(+17.9%) | $72.22 M(-5.4%) |
| Sept 2016 | - | $76.31 M(-3.8%) |
| June 2016 | - | $79.28 M(+20.2%) |
| Mar 2016 | - | $65.94 M(+7.7%) |
| Dec 2015 | $61.25 M(-4.4%) | $61.25 M(-70.6%) |
| Sept 2015 | - | $208.10 M(+156.7%) |
| June 2015 | - | $81.08 M(+7.5%) |
| Mar 2015 | - | $75.44 M(+17.8%) |
| Dec 2014 | $64.05 M(-34.8%) | $64.05 M(-20.5%) |
| Sept 2014 | - | $80.55 M(-4.5%) |
| June 2014 | - | $84.36 M(+6.4%) |
| Mar 2014 | - | $79.31 M(-19.3%) |
| Dec 2013 | $98.22 M(+25.1%) | $98.22 M(+21.4%) |
| Sept 2013 | - | $80.91 M(-10.4%) |
| June 2013 | - | $90.28 M(+8.5%) |
| Mar 2013 | - | $83.22 M(+6.0%) |
| Dec 2012 | $78.54 M(-71.5%) | $78.54 M(+13.1%) |
| Sept 2012 | - | $69.47 M(-74.9%) |
| June 2012 | - | $276.86 M(+2.3%) |
| Mar 2012 | - | $270.75 M(-1.7%) |
| Dec 2011 | $275.53 M(+329.8%) | $275.53 M(-1.3%) |
| Sept 2011 | - | $279.04 M(+355.4%) |
| June 2011 | - | $61.27 M(+4.1%) |
| Mar 2011 | - | $58.88 M(-8.2%) |
| Dec 2010 | $64.11 M(-58.1%) | $64.11 M(-24.4%) |
| Sept 2010 | - | $84.83 M(-21.1%) |
| June 2010 | - | $107.47 M(-14.5%) |
| Mar 2010 | - | $125.64 M(-17.9%) |
| Dec 2009 | $153.02 M | $153.02 M(+210.0%) |
| Sept 2009 | - | $49.36 M(+8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $45.32 M(-2.8%) |
| Mar 2009 | - | $46.64 M(-31.8%) |
| Dec 2008 | $68.37 M(-30.3%) | $68.37 M(+40.9%) |
| Sept 2008 | - | $48.52 M(-17.4%) |
| June 2008 | - | $58.76 M(+1.9%) |
| Mar 2008 | - | $57.65 M(-41.2%) |
| Dec 2007 | $98.09 M(-40.7%) | $98.09 M(-37.4%) |
| Sept 2007 | - | $156.68 M(+29.1%) |
| June 2007 | - | $121.33 M(+8.8%) |
| Mar 2007 | - | $111.48 M(-32.6%) |
| Dec 2006 | $165.31 M(+137.5%) | $165.31 M(+73.4%) |
| Sept 2006 | - | $95.33 M(-17.0%) |
| June 2006 | - | $114.84 M(+4.1%) |
| Mar 2006 | - | $110.30 M(+58.5%) |
| Dec 2005 | $69.59 M(+25.1%) | $69.59 M(+45.5%) |
| Sept 2005 | - | $47.83 M(-12.3%) |
| June 2005 | - | $54.54 M(+5.9%) |
| Mar 2005 | - | $51.49 M(-7.5%) |
| Dec 2004 | $55.65 M(+18.8%) | $55.65 M(+44.7%) |
| Sept 2004 | - | $38.45 M(-15.0%) |
| June 2004 | - | $45.24 M(-8.7%) |
| Mar 2004 | - | $49.54 M(+5.7%) |
| Dec 2003 | $46.86 M(-26.4%) | $46.86 M(-4.0%) |
| Sept 2003 | - | $48.80 M(+8.7%) |
| June 2003 | - | $44.89 M(+9.2%) |
| Mar 2003 | - | $41.12 M(-35.4%) |
| Dec 2002 | $63.66 M(+7.5%) | $63.66 M(+25.1%) |
| Sept 2002 | - | $50.91 M(-12.0%) |
| June 2002 | - | $57.84 M(-2.6%) |
| Mar 2002 | - | $59.38 M(+0.3%) |
| Dec 2001 | $59.20 M(+96.0%) | $59.20 M(+31.8%) |
| Sept 2001 | - | $44.91 M(-23.5%) |
| June 2001 | - | $58.75 M(+48.8%) |
| Mar 2001 | - | $39.47 M(+30.7%) |
| Dec 2000 | $30.20 M(+20.4%) | $30.20 M(+40.4%) |
| Sept 2000 | - | $21.52 M(-29.4%) |
| June 2000 | - | $30.50 M(-4.5%) |
| Mar 2000 | - | $31.95 M(+27.4%) |
| Dec 1999 | $25.08 M(+96.6%) | $25.08 M(+56.5%) |
| Sept 1999 | - | $16.03 M(+2.5%) |
| June 1999 | - | $15.63 M(+6.6%) |
| Mar 1999 | - | $14.66 M(+14.9%) |
| Dec 1998 | $12.76 M(-25.5%) | $12.76 M(+23.0%) |
| Sept 1998 | - | $10.37 M(-20.7%) |
| June 1998 | - | $13.08 M(-10.7%) |
| Mar 1998 | - | $14.64 M(-14.4%) |
| Dec 1997 | $17.11 M(+176.0%) | $17.11 M(+17.1%) |
| Sept 1997 | - | $14.62 M(+15.8%) |
| June 1997 | - | $12.63 M(+37.0%) |
| Mar 1997 | - | $9.21 M(+48.6%) |
| Dec 1996 | $6.20 M(+129.6%) | $6.20 M(+87.9%) |
| Sept 1996 | - | $3.30 M(+6.5%) |
| June 1996 | - | $3.10 M(+24.0%) |
| Mar 1996 | - | $2.50 M(-7.4%) |
| Dec 1995 | $2.70 M(+92.9%) | $2.70 M(+12.5%) |
| Sept 1995 | - | $2.40 M(0.0%) |
| June 1995 | - | $2.40 M(0.0%) |
| Mar 1995 | - | $2.40 M(+71.4%) |
| Dec 1994 | $1.40 M | $1.40 M(-33.3%) |
| Sept 1994 | - | $2.10 M(+23.5%) |
| June 1994 | - | $1.70 M(+13.3%) |
| Mar 1994 | - | $1.50 M |
FAQ
- What is Nektar Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Nektar Therapeutics?
- What is Nektar Therapeutics annual current liabilities year-on-year change?
- What is Nektar Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly current liabilities year-on-year change?
What is Nektar Therapeutics annual total current liabilities?
The current annual current liabilities of NKTR is $51.27 M
What is the all time high annual current liabilities for Nektar Therapeutics?
Nektar Therapeutics all-time high annual total current liabilities is $353.89 M
What is Nektar Therapeutics annual current liabilities year-on-year change?
Over the past year, NKTR annual total current liabilities has changed by -$16.93 M (-24.83%)
What is Nektar Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of NKTR is $67.58 M
What is the all time high quarterly current liabilities for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly total current liabilities is $377.47 M
What is Nektar Therapeutics quarterly current liabilities year-on-year change?
Over the past year, NKTR quarterly total current liabilities has changed by +$15.47 M (+29.69%)